BioCentury
ARTICLE | Company News

Affinivax, Nosocomial Vaccine deal

November 16, 2015 8:00 AM UTC

Nosocomial Vaccine (NVC) partnered with Affinivax to develop vaccines to prevent nosocomial infections. The collaboration will utilize Affinivax’s Multiple Antigen Presentation System (MAPS) vaccine platform to develop the bacterial nosocomial infection vaccines. NVC will provide funding to develop candidates towards clinical testing. ...